Agerholm-Larsen, L, Raben, A, Haulrik, N, Hansen, AS, Manders, M & Astrup, A (2000) Effect of 8 week intake of probiotic milk products on risk factors for cardiovascular diseases. Eur J Clin Nutr 54, 288–297.
Aldini, R, Roda, A, Montagnani, M, Cerrè, C, Pellicciari, R & Roda, E (1996) Relationship between structure and intestinal absorption of bile acids with a steroid or side-chain modification. Steroids 61, 590–597.
Bachrach, WH & Hofmann, AF (1982) Ursodeoxycholic acid treatment of cholesterol cholelithiasis Part II. Dig Dis Sci 27, 833–856.
Baijal, PK, Fitzpatrick, DW & Bird, RP (1998) Comparative effects of secondary bile acids, deoxycholic and lithocholic acids, on aberrant crypt foci growth in the postinitiation phases of colon carcinogenesis. Nutr Cancer 31, 81–89.
Baron, SF, Franklund, CV & Hylemon, PB (1991) Cloning, sequencing, and expression of the gene coding for bile acid 7α-hydroxysteroid dehydrogenase from Eubacterium sp. strain VPI 12708. J Bacteriol 173, 4558–4569.
Batta, AK, Salen, G, Holubec, H, Brasitus, TA, Alberts, D & Earnest, DL (1998) Enrichment of the more hydrophilic bile acid ursodeoxycholic acid in the fecal water-soluble fraction after feeding to rats with colon polyps. Cancer Res 58, 1684–1687.
Bennett, MJ, McKnight, SL & Coleman, JP (2003) Cloning and characterization of the NAD-dependent 7α-hydroxysteroid dehydrogenase from Bacteroides fragilis. Curr Microbiol 47, 475–484.
Brown, I, Warhurst, M, Arcot, J, Playne, M, Illman, RJ & Topping, DL (1997) Fecal numbers of bifidobacteria are higher in pigs fed Bifidobacterium longum with a high amylose cornstarch than with a low amylose cornstarch. J Nutr 127, 1822–1827.
Chen, RM, Wu, JJ, Lee, SC, Huang, AH & Wu, HM (1999) Increase of intestinal Bifidobacterium and suppression of coliform bacteria with short-term yogurt ingestion. J Dairy Sci 82, 2308–2314.
Coleman, JP, Hudson, LL & Adams, MJ (1994) Characterization and regulation of the NADP-linked 7α-hydroxysteroid dehydrogenase gene from Clostridium sordellii. J Bacteriol 176, 4865–4874.
Colombo, C, Setchell, KD, Podda, M, Crosignani, A, Roda, A, Curcio, L, Ronchi, M & Giunta, A (1990) Effects of ursodeoxycholic acid therapy for liver disease associated with cystic fibrosis. J Pediatr 117, 482–489.
Combes, B, Carithers, RL Jr, Maddrey, WC, Lin, D, McDonald, MF, Wheeler, DE, Eigenbrodt, EH, Munoz, SJ, Rubin, R & Garcia-Tsao, G (1995) A randomized, double-blind, placebo-controlled trial of ursodeoxycholic acid in primary biliary cirrhosis. Hepatology 22, 759–766.
Crosignani, A, Setchell, KD, Invernizzi, P, Larghi, A, Rodrigues, CM & Podda, M (1996) Clinical pharmacokinetics of therapeutic bile acids. Clin Pharmacokinet 30, 333–358.
De Rodas, BZ, Gilliland, SE & Maxwell, CV (1996) Hypocholesterolemic action of Lactobacillus acidophilus ATCC 43121 and calcium in swine with hypercholesterolemia induced by diet. J Dairy Sci 79, 2121–2128.
De Smet, I, De Boever, P & Verstraete, W (1998) Cholesterol lowering in pigs through enhanced bacterial bile salt hydrolase activity. Br J Nutr 79, 185–194.
Drouault, S & Corthier, G (2001) Health effects of lactic acid bacteria ingested in fermented milk. Vet Res 32, 101–117.
Drouault, S, Anba, J & Corthier, G (2002) Streptococcus thermophilus is able to produce a β-galactosidase active during its transit in the digestive tract of germ-free mice. Appl Environ Microbiol 68, 938–941.
Earnest, DL, Holubec, H, Wali, RK, Jolley, CS, Bissonette, M, Bhattacharyya, AK, Roy, H, Khare, S & Brasitus, TA (1994) Chemoprevention of azoxymethane-induced colonic carcinogenesis by supplemented dietary ursodeoxycholic acid. Cancer Res 54, 5071–5074.
Ellis, E, Axelson, M, Abrahamsson, A, Eggertsen, G, Thorne, A, Nowak, G, Ericzon, BG, Bjorkhem, I & Einarsson, C (2003) Feedback regulation of bile acid synthesis in primary human hepatocytes: evidence that CDCA is the strongest inhibitor. Hepatology 38, 930–938.
Fedorowski, T, Salen, G, Tint, GS & Mosbach, E (1979) Transformation of chenodeoxycholic acid and ursodeoxycholic acid by human intestinal bacteria. Gastroenterology 77, 1068–1073.
Ferezou, J, Riottot, M & Serougne, C, et al. (1997) Hypocholesterolemic action of β-cyclodextrin and its effects on cholesterol metabolism in pigs fed a cholesterol-enriched diet. J Lipid Res 38, 86–100.
Fischer, S, Neubrand, M & Paumgartner, G (1993) Biotransformation of orally administered ursodeoxycholic acid in man as observed in gallbladder bile, serum and urine. Eur J Clin Invest 23, 28–36.
Fossati, P & Prencipe, L (1982) Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide. Clin Chem 28, 2077–2080.
Fujiwara, S, Seto, Y, Kimura, A & Hashiba, H (2001) Intestinal transit of an orally administered streptomycin-rifampicin-resistant variant of Bifidobacterium longum SBT2928: its long-term survival and effect on the intestinal microflora and metabolism. J Appl Microbiol 90, 43–52.
Hayase, M, Mitsui, N, Tamai, K, Nakamura, S & Nishida, S (1974) Isolation of Clostridium absonum and its cultural and biochemical properties. Infect Immun 9, 15–19.
Hirano, S, Nakama, R, Tamaki, M, Masuda, N & Oda, H (1981) Isolation and characterization of thirteen intestinal microorganisms capable of 7α-dehydroxylating bile acids. Appl Environ Microbiol 41, 737–745.
Hungate, RE (1969) A roll tube method for cultivation of strict anaerobes. Methods Microbiol 3, 117–132.
Invernizzi, P, Setchell, KD, Crosignani, A, Battezzati, PM, Larghi, A, O'Connell, NC & Podda, M (1999) Differences in the metabolism and disposition of ursodeoxycholic acid and its taurine-conjugated species in patients with primary biliary cirrhosis. Hepatology 29, 320–327.
Juste, C, Corring, T & Le Coz, Y (1983) Bile restitution procedures for studying bile secretion in fistulated pigs. Lab Anim Sci 33, 199–202.
Kenward, MG & Roger, JH (1997) Small sample inference for fixed effects from restricted maximum likelihood. Biometrics 53, 983–997.
Kozoni, V, Tsioulias, G, Shiff, S & Rigas, B (2000) The effect of lithocholic acid on proliferation and apoptosis during the early stages of colon carcinogenesis: differential effect on apoptosis in the presence of a colon carcinogen. Carcinogenesis 21, 999–1005.
Latta, RK, Fiander, H, Ross, NW, Simpson, C & Schneider, H (1993) Toxicity of bile acids to colon cancer cell lines. Cancer Lett 16, 167–173.
Legrand-Defretin, V, Juste, C, Corring, T & Rerat, A (1986) Enterohepatic circulation of bile acids in pigs: diurnal pattern and effect of a reentrant biliary fistula. Am J Physiol 250, G295–G301.
Lepercq, P, Gérard, P, Béguet, F, Raibaud, P, Grill, JP, Relano, P, Cayuela, C & Juste, C (2004a) Epimerization of chenodeoxycholic acid to ursodeoxycholic acid by Clostridium baratii isolated from human feces. FEMS Microbiol Lett 235, 65–72.
Lepercq, P, Gérard, P, Béguet, F, Grill, JP, Relano, P, Cayuela, C & Juste, C (2004b) Isolates from normal human intestinal flora but not lactic acid bacteria exhibit 7α- and 7β-hydroxysteroid dehydrogenase activities. Microbial Ecol Health Dis 16, 195–201.
Lepercq, P, Relano, P, Cayuela, C & Juste, C (2004c) Bifidobacterium animalis strain DN-173 010 hydrolyses bile salts in the gastrointestinal tract of pigs. Scand J Gastroenterol 39, 1266–1271.
Lindor, KD, Lacerda, MA, Jorgensen, RA, DeSotel, CK, Batta, AK, Salen, G, Dickson, ER, Rossi, SS & Hofmann, AF (1998) Relationship between biliary and serum bile acids and response to ursodeoxycholic acid in patients with primary biliary cirrhosis. Am J Gastroenterol 93, 1498–1504.
Macdonald, IA & Roach, PD (1981) Bile salt induction of 7α- and 7β-hydroxysteroid dehydrogenases in Clostridium absonum. Biochim Biophys Acta 665, 262–269.
Macdonald, IA, Hutchison, DM & Forrest, TP (1981) Formation of urso- and ursodeoxy-cholic acids from primary bile acids by Clostridium absonum. J Lipid Res 22, 458–466.
Marsh, A, Kim, DN, Lee, KT, Reiner, JM & Thomas, WA (1972) Cholesterol turnover, synthesis, and retention in hypercholesterolemic growing swine. J Lipid Res 13, 600–615.
Nowak, G, Ungerstedt, J, Marschall, H-U, Einarsson, C & Ericzon, B-G (2001) Pre-treatment with ursodeoxycholic acid diminishes nonoxidative glycolysis in a pig liver transplantation model. Hepatology 34 294A
Oyama, K, Shiota, G, Ito, H, Murawaki, Y & Kawasaki, H (2002) Reduction of hepatocarcinogenesis by ursodeoxycholic acid in rats. Carcinogenesis 23, 885–892.
Pereira, DI & Gibson, GR (2002) Effects of consumption of probiotics and prebiotics on serum lipid levels in humans. Crit Rev Biochem Mol Biol 37, 259–281.
Pochart, P, Marteau, P, Bouhnik, Y, Goderel, I, Bourlioux, P & Rambaud, J-C (1992) Survival of bifidobacteria ingested via fermented milk during their passage through the human small intestine: an in vivo study using intestinal perfusion. Am J Clin Nutr 55, 78–80.
Podda, M, Ghezzi, C, Battezzati, PM, Crosignani, A, Zuin, M & Roda, A (1990) Effects of ursodeoxycholic acid and taurine on serum liver enzymes and bile acids in chronic hepatitis. Gastroenterology 98, 1044–1050.
Ponz de Leon, M, Carulli, N, Loria, P, Iori, R & Zironi, F (1980) Cholesterol absorption during bile acid feeding: effect of ursodeoxycholic acid (UDCA) administration. Gastroenterology 78, 214–219.
Poupon, RE, Ouguerram, K, Chrétien, Y, Verneau, C, Eschwège, E, Magot, T & Poupon, R (1993) Cholesterol-lowering effect of ursodeoxycholic acid in patients with primary biliary cirrhosis. Hepatology 17, 577–582.
Raicht, RF, Cohen, BI, Sarwal, A & Takahashi, M (1978) Ursodeoxycholic acid. Effects on sterol metabolism in rats. Biochim Biophys Acta 531, 1–8.
Reynier, MO, Montet, JC, Gerolami, A, Marteau, C, Crotte, C, Montet, AM & Mathieu, S (1981) Comparative effects of cholic, chenodeoxycholic, and ursodeoxycholic acids on micellar solubilization and intestinal absorption of cholesterol. J Lipid Res 22, 467–473.
Richelsen, B, Kristensen, K & Pedersen, SB (1996) Long-term (6 months) effect of a new fermented milk product on the level of plasma lipoproteins – a placebo-controlled and double blind study. Eur J Clin Nutr 50, 811–815.
Richmond, W (1973) Preparation and properties of a cholesterol oxidase from Nocardia sp. and its application to the enzymatic assay of total cholesterol in serum. Clin Chem 19, 1350–1356.
Riottot, M, Olivier, P, Huet, A, Caboche, J-J, Parquet, M, Khallou, J & Lutton, C (1993) Hypolipidemic effects of β-cyclodextrin in the hamster and in the genetically hypercholesterolemic Rico rat. Lipids 28, 181–188.
Roberfroid, MB (2000) Prebiotics and probiotics: are they functional foods? Am J Clin Nutr 71, 1682S – 1687S discussion 1688S–1690S.
Sarva, RP, Fromm, H, Carlson, GL, Mendelow, L & Ceryak, S (1980) Intracolonic conversion in man of chenodeoxycholic acid (CDC) to ursodeoxycholic acid (UDC) with and without formation of 7-keto lithocholic acid (KLC) as an intermediate. Gastroenterology 78, 1252 Abstr
Seraj, MJ, Umemoto, A, Kajikawa, A, Mimura, S, Kinouchi, T, Ohnishi, Y & Monden, Y (1997) Effects of dietary bile acids on formation of azoxymethane-induced aberrant crypt foci in F344 rats. Cancer Lett 115, 97–103.
Shimizu, H, Yoshii, M, Seki, A, Une, M & Hoshita, T (1992) Hypocholesterolemic effect of ursodeoxycholylcysteic acid in hamsters fed a high cholesterol diet. J Pharmacobiodyn 15, 573–580.
Simoni, P, Cerrè, C, Cipolla, A, Polimeni, C, Pistillo, A, Ceschel, G, Roda, E & Roda, A (1995) Bioavailability study of a new, sinking, enteric-coated ursodeoxycholic acid formulation. Pharmacol Res 31, 115–119.
Sutherland, JD & Williams, CN (1985) Bile acid induction of 7α- and 7β-hydroxysteroid dehydrogenases in Clostridium limosum. J Lipid Res 26, 344–350.
Takayama, M, Itoh, S, Nagasaki, T & Tanimizu, I (1977) A new enzymatic method for determination of serum choline-containing phospholipids. Clin Chim Acta 79, 93–98.
Taranto, MP, Medici, M, Perdigon, G, Ruiz, Holgado AP & Valdez, GF (1998) Evidence for hypocholesterolemic effect of Lactobacillus reuteri in hypercholesterolemic mice. J Dairy Sci 81, 2336–2340.
Turley, SD & Dietschy, JM (1978) Re-evaluation of the 3α-hydroxysteroid dehydrogenase assay for total bile acids in bile. J Lipid Res 19, 924–928.
Usman, HA (2001) Hypocholesterolemic effect of Lactobacillus gasseri SBT0270 in rats fed a cholesterol-enriched diet. J Dairy Res 68, 617–624.
van Gorkom, BA, van der Meer, R, Boersma-van Ek, W, Termont, DS, de Vries, EG & Kleibeuker, JH (2002) Changes in bile acid composition and effect on cytolytic activity of fecal water by ursodeoxycholic acid administration: a placebo-controlled cross-over intervention trial in healthy volunteers. Scand J Gastroenterol 37, 965–971.
Varnam, AH & Sutherland, JP (1994) Milk and Milk Products: Technology, Chemistry and Microbiology, 347–380. London: Chapman & Hall.
Wali, RK, Stoiber, D, Nguyen, L, Hart, J, Sitrin, MD, Brasitus, T & Bissonnette, M (2002) Ursodeoxycholic acid inhibits the initiation and postinitiation phases of azoxymethane-induced colonic tumor development. Cancer Epidemiol Biomarkers Prev 11, 1316–1321.
Wang, X, Brown, IL, Evans, AJ & Conway, PL (1999) The protective effects of high amylose maize (amylomaize) starch granules on the survival of Bifidobacterium spp. in the mouse intestinal tract. J Appl Microbiol 87, 631–639.
Woollett, LA, Buckley, DD, Yao, L, Jones, PJ, Granholm, NA, Tolley, EA & Heubi, JE (2003) Effect of ursodeoxycholic acid on cholesterol absorption and metabolism in humans. J Lipid Res 44, 935–942.
Xiao, JZ, Kondo, S, Takahashi, N, Miyaji, K, Oshida, K, Hiramatsu, A, Iwatsuki, K, Kokubo, S & Hosono, A (2003) Effects of milk products fermented by Bifidobacterium longum on blood lipids in rats and healthy adult male volunteers. J Dairy Sci 86, 2452–2461.
Yoshimoto, T, Higashi, H, Kanatani, A, Lin, XS, Nagai, H, Oyama, H, Kurazono, K & Tsuru, D (1991) Cloning and sequencing of the 7α-hydroxysteroid dehydrogenase gene from Escherichia coli HB 101 and characterization of the expressed enzyme. J Bacteriol 173, 2173–2179.